157 related articles for article (PubMed ID: 6146006)
1. Prophylactic oral acyclovir in recurrent genital herpes.
Mindel A; Weller IV; Faherty A; Sutherland S; Hindley D; Fiddian AP; Adler MW
Lancet; 1984 Jul; 2(8394):57-9. PubMed ID: 6146006
[TBL] [Abstract][Full Text] [Related]
2. Double-blind, placebo-controlled trial comparing long-term suppressive with short-term oral acyclovir therapy for management of recurrent genital herpes.
Mattison HR; Reichman RC; Benedetti J; Bolgiano D; Davis LG; Bailey-Farchione A; Remington M; Winter C; Corey L
Am J Med; 1988 Aug; 85(2A):20-5. PubMed ID: 3044086
[TBL] [Abstract][Full Text] [Related]
3. Long-term oral acyclovir treatment prevents recurrent genital herpes.
Blom I; Bäck O; Egelrud T; Frödin T; Hellbe L; Johannisson G; Malmros-Enander I; Molin L
Dermatologica; 1986; 173(5):220-3. PubMed ID: 3100353
[TBL] [Abstract][Full Text] [Related]
4. Recurrent genital herpes suppressed by oral acyclovir: a multicentre double blind trial.
Thin RN; Jeffries DJ; Taylor PK; Ayra OP; Rodin P; Yeo J; Fiddian AP
J Antimicrob Chemother; 1985 Aug; 16(2):219-26. PubMed ID: 3905750
[TBL] [Abstract][Full Text] [Related]
5. Dosage and safety of long-term suppressive acyclovir therapy for recurrent genital herpes.
Mindel A; Faherty A; Carney O; Patou G; Freris M; Williams P
Lancet; 1988 Apr; 1(8591):926-8. PubMed ID: 2895840
[TBL] [Abstract][Full Text] [Related]
6. Oral acyclovir suppressive therapy in severe recurrent genital herpes. A double-blind, placebo-controlled cross-over study.
Kroon S; Petersen CS; Andersen LP; Rasmussen LP; Vestergaard BF
Dan Med Bull; 1989 Jun; 36(3):298-300. PubMed ID: 2666040
[TBL] [Abstract][Full Text] [Related]
7. Acyclovir prophylaxis of recurrent genital herpes: randomised placebo controlled crossover study.
Kinghorn GR; Jeavons M; Rowland M; Abeywickreme I; Barton IG; Potter CW; Hickmott EA
Genitourin Med; 1985 Dec; 61(6):387-90. PubMed ID: 3910546
[TBL] [Abstract][Full Text] [Related]
8. Intravenous acyclovir therapy of first episodes of genital herpes: a multicenter double-blind, placebo-controlled trial.
Peacock JE; Kaplowitz LG; Sparling PF; Durack DT; Gnann JW; Whitley RJ; Lovett M; Bryson YJ; Klein RJ; Friedman-Kien AE
Am J Med; 1988 Sep; 85(3):301-6. PubMed ID: 3046350
[TBL] [Abstract][Full Text] [Related]
9. A double-blind study of oral acyclovir for suppression of recurrences of genital herpes simplex virus infection.
Douglas JM; Critchlow C; Benedetti J; Mertz GJ; Connor JD; Hintz MA; Fahnlander A; Remington M; Winter C; Corey L
N Engl J Med; 1984 Jun; 310(24):1551-6. PubMed ID: 6328298
[TBL] [Abstract][Full Text] [Related]
10. One-year suppression of frequent recurrences of genital herpes with oral acyclovir.
Baker DA; Blythe JG; Kaufman R; Hale R; Portnoy J
Obstet Gynecol; 1989 Jan; 73(1):84-7. PubMed ID: 2642329
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of oral acyclovir in the treatment of initial and recurrent genital herpes.
Nilsen AE; Aasen T; Halsos AM; Kinge BR; Tjøtta EA; Wikström K; Fiddian AP
Lancet; 1982 Sep; 2(8298):571-3. PubMed ID: 6125728
[TBL] [Abstract][Full Text] [Related]
12. Acyclovir in first attacks of genital herpes and prevention of recurrences.
Mindel A; Weller IV; Faherty A; Sutherland S; Fiddian AP; Adler MW
Genitourin Med; 1986 Feb; 62(1):28-32. PubMed ID: 3512419
[TBL] [Abstract][Full Text] [Related]
13. Suppression of frequently recurring genital herpes: acyclovir v inosine pranobex.
Mindel A; Carney O; Sonnex C; Freris M; Patou G; Williams P
Genitourin Med; 1989 Apr; 65(2):103-5. PubMed ID: 2473952
[TBL] [Abstract][Full Text] [Related]
14. Chronic suppression for six months compared with intermittent lesional therapy of recurrent genital herpes using oral acyclovir: effects on lesions and nonlesional prodromes.
Sacks SL; Fox R; Levendusky P; Stiver HG; Roland S; Nusinoff-Lehrman S; Keeney R
Sex Transm Dis; 1988; 15(1):58-62. PubMed ID: 3282336
[TBL] [Abstract][Full Text] [Related]
15. Suppression of frequently recurring genital herpes. A placebo-controlled double-blind trial of oral acyclovir.
Straus SE; Takiff HE; Seidlin M; Bachrach S; Lininger L; DiGiovanna JJ; Western KA; Smith HA; Lehrman SN; Creagh-Kirk T
N Engl J Med; 1984 Jun; 310(24):1545-50. PubMed ID: 6328297
[TBL] [Abstract][Full Text] [Related]
16. Double-blind placebo-controlled trial of oral acyclovir in first-episode genital herpes simplex virus infection.
Mertz GJ; Critchlow CW; Benedetti J; Reichman RC; Dolin R; Connor J; Redfield DC; Savoia MC; Richman DD; Tyrrell DL
JAMA; 1984 Sep; 252(9):1147-51. PubMed ID: 6088819
[TBL] [Abstract][Full Text] [Related]
17. A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections. The Valaciclovir International Study Group.
Tyring SK; Douglas JM; Corey L; Spruance SL; Esmann J
Arch Dermatol; 1998 Feb; 134(2):185-91. PubMed ID: 9487210
[TBL] [Abstract][Full Text] [Related]
18. Suppression of recurrent genital herpes by single daily dosages of acyclovir.
Mostow SR; Mayfield JL; Marr JJ; Drucker JL
Am J Med; 1988 Aug; 85(2A):30-3. PubMed ID: 3044089
[TBL] [Abstract][Full Text] [Related]
19. Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir. A randomized double-blind controlled trial in normal subjects.
Bryson YJ; Dillon M; Lovett M; Acuna G; Taylor S; Cherry JD; Johnson BL; Wiesmeier E; Growdon W; Creagh-Kirk T; Keeney R
N Engl J Med; 1983 Apr; 308(16):916-21. PubMed ID: 6339923
[TBL] [Abstract][Full Text] [Related]
20. Prolonged continuous versus intermittent oral acyclovir treatment in normal adults with frequently recurring genital herpes simplex virus infection.
Mertz GJ; Eron L; Kaufman R; Goldberg L; Raab B; Conant M; Mills J; Kurtz T; Davis LG
Am J Med; 1988 Aug; 85(2A):14-9. PubMed ID: 3044076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
